Review Study Guide Solutions
Low-dose colchine - ANSWER✔✔-1.2 mg at first sign of flare, followed by 0.6 mg one
hour later for a total dose of 1.8 mg.
High-dose colchine - ANSWER✔✔-1.2 mg followed by 0.6 mg every 4-6 hours totaling
4.8 mg.
Gout - ANSWER✔✔-BUN, creatinine, and creatinine clearance should be monitored in
the treatment of this disease
Colchine - ANSWER✔✔-This medication can cause severe diarrhea, nausea, vomiting,
abdominal pain
Febuxostat (Uloric) - ANSWER✔✔-When prescribing this medication, patients should
be taught that gout may worsen with therapy before it improves
Corticosteroids - ANSWER✔✔-These medications can cause the following adverse
effects if taken for six months or more: Osteoporosis and poor diabetic control. Patients
should report black, tarry stools or abdominal pain.
Copyright ©SOPHIABENNETT 2025 ACADEMIC YEARALL RIGHTS RESERVED. Page 1/9
, Corticosteroids - ANSWER✔✔-These medications should be tapered to avoid recurrent
activity of the underlying disease and possible cortisol deficiency resulting from the
hypothalamic-pituitary-adrenal axis suppression during the period of steroid therapy.
Black Box Warning on NSAIDS - ANSWER✔✔-Increased risk of serious cardiovascular
thrombotic events, such as myocardial infarction and stroke. These medications can also
cause serious GI events such as bleeding, ulceration or perforation of stomach or
intestines, which can be fatal.
Pain management - ANSWER✔✔-When treating this common issue, it is recommended
to begin with NSAIDS and work up from there as needed
Ibuprofen - ANSWER✔✔-This medication works by inhibiting the COX enzymes;
however, the exact mechanism of action for this particular medication is unknown.
Acetaminophen - ANSWER✔✔-A serious adverse effect related to this medication is
referred to as "------------- poisoning"
Symptoms of hypoglycemia - ANSWER✔✔-Decreased LOC, hunger, diaphoresis,
weakness, dizziness and tachycardia
Symptoms of hyperglycemia - ANSWER✔✔-Polyuria, polydipsia and polyphagia
(weight loss)
Copyright ©SOPHIABENNETT 2025 ACADEMIC YEARALL RIGHTS RESERVED. Page 2/9